FDA Drug recall D-1277-2014
Adipotrim XT, New Powerful Formula, 30 rapid release capsules per bottle, Dietary Supplement, www.adipotrim.com
- FDA Drug
- Class I
- terminated
- Published 2014-05-07
On 2014-05-07 the FDA classified a Class I recall of Adipotrim XT, New Powerful Formula, 30 rapid release capsules per bottle, Dietary Supplement, www.adipotrim.com by Deseo Rebajar, citing marketed Without an Approved NDA/ANDA: FDA lab results found undeclared API Fluoxetine in this dietary supplement.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1277-2014 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2013-11-07 |
| Published | 2014-05-07 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Deseo Rebajar |
| Distribution | US |
Product
Adipotrim XT, New Powerful Formula, 30 rapid release capsules per bottle, Dietary Supplement, www.adipotrim.com.
Reason
Marketed Without an Approved NDA/ANDA: FDA lab results found undeclared API Fluoxetine in this dietary supplement.
Identifiers
| code_info | Lot #: 052012, Exp 10/2015 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1277-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.